#TumorDevelopment
This month, Dr. Harsh Dongre from Boston Children’s Hospital will present his research on #NRP2 and #TumorDevelopment! Register now for this #VirtualSeminar https://bit.ly/4fLoqu7
#ASIPwebinar #pathobiology
August 6, 2026 at 3:35 PM
Next month, Dr. Harsh Dongre from Boston Children’s Hospital will present his research on #NRP2 and #TumorDevelopment! Register now for this #VirtualSeminar bit.ly/4fLoqu7

#ASIPwebinar #pathobiology
July 21, 2026 at 2:00 PM
Tamoxifen circumvents the need for genetic mutations in the PI3K signaling pathway by directly providing the stimulus for tumor development.

#oncology #tumordevelopment #breastcancer

doi.org/10.1038/s415...
Tamoxifen induces PI3K activation in uterine cancer - Nature Genetics
Sequencing analysis of tamoxifen-associated uterine cancers and further in vivo analyses suggest that the drug tamoxifen can activate the PI3K pathway in the absence of oncogenic mutations.
doi.org
August 29, 2025 at 8:29 AM
Extracellular vesicles—a new player in the development of urinary bladder cancer - Therapeutic Advances in Medical Oncology - Jan 23, 2025 @journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#EVs #cancermetastasis #tumordevelopment #cancerresearch
February 21, 2025 at 11:40 PM